2m 2m 2m 2m 2m 2m 2m
ANIXA BIOSCINCS (ANIX)
NASDAQ
$2.66-$0.02 (-0.71%)
Price as of Nov 13, 2026 2:16 PM EST- $93.2MMarket Cap
- -38.95%1-Year Change
- BiotechnologyIndustry
ANIXA BIOSCINCS (ANIX)
$2.66-$0.02 (-0.71%)
ANIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.68 | ||
Change | -$0.10 (-3.60%) | ||
Open | $2.72 | ||
High | $2.85 | ||
Low | $2.66 | ||
Previous Close | $2.78 | ||
Volume | 276,283 | ||
30-Day Average Volume | 192,492 | ||
1-Week Change | -11.55% | ||
1-Month Change | -5.63% | ||
1-Year Change | -38.95% | ||
3-Year Change | -8.53% | ||
5-Year Change | -42.74% | ||
Fundamentals | |||
Shares Outstanding | 34.8M | ||
Total Assets | $15.1M | ||
Market Cap | $93.2M | ||
Enterprise Value | $91.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $13.2M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -34 | ||
PEG | 2 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||